Veterinary Medicines

Vanguard 7

Authorised
  • Canine parainfluenza virus, strain NL-CPI-5, Live
  • Canine distemper virus, strain N-CDV, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parvovirus, strain NL-35-D, Live
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
Download as PDF

Product identification

Medicine name:
Vanguard 7
Active substance:
  • Canine parainfluenza virus, strain NL-CPI-5, Live
  • Canine distemper virus, strain N-CDV, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parvovirus, strain NL-35-D, Live
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parainfluenza virus, strain NL-CPI-5, Live
    8.00
    log10 cell culture infective dose 50
    /
    1.00
    Vial
  • Canine distemper virus, strain N-CDV, Live
    316228.00
    cell culture infective dose 50
    /
    1.00
    Vial
  • Canine adenovirus 2, strain Manhattan, Live
    158489.00
    cell culture infective dose 50
    /
    1.00
    Vial
  • Canine parvovirus, strain NL-35-D, Live
    8.50
    log10 cell culture infective dose 50
    /
    1.00
    Vial
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
    422.00
    unit(s)
    /
    1.00
    Dose
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
    493.00
    unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Blister containing 25 glass (Type I) vials with rubber stopper and metal cap containing 1 dose of liquid vaccine fraction as suspending liquid and 1 dose of freeze-dried

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Zoetis B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 8369
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 29/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."